# Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder

> **NCT05098574** · PHASE2 · COMPLETED · sponsor: **St. Joseph's Healthcare Hamilton** · enrollment: 17 (actual)

## Conditions studied

- Premenstrual Dysphoric Disorder
- Bipolar Disorder

## Interventions

- **DRUG:** Yaz
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05098574
- **Lead sponsor:** St. Joseph's Healthcare Hamilton
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-03
- **Primary completion:** 2024-04-11
- **Final completion:** 2024-04-11
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2024-09-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05098574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05098574, "Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05098574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*